EPIX ESSA Pharma
- 1.790
- 0.0000.00%
- 1.790
- 0.0000.00%
ESSA Pharma News
Earnings Week Ahead: CRM, DOCU, OKTA, ZS, S, MRVL, LULU, DG, and More
Express News | Tang Capital Management, LLC Reports 9.7% Stake in ESSA Pharma as of Nov 1- SEC Filing
ESSA Pharma(EPIX.US) 10% Shareholder Sells US$12.02 Million in Common Stock
ESSA Pharma Slides As Insider Purchases Lose Another US$211k
ESSA Pharma Downgraded by Oppenheimer, Piper Sandler After Drug Setback in Trials
Express News | ESSA Pharma Shares Are Trading Lower After Oppenheimer Downgraded the Stock From Outperform to Perform. Piper Sandler Downgraded Its Rating From Overweight to Neutral and Cut Its Price Target From $15 to $2
Essa Pharma Price Target Cut to $2.00/Share From $15.00 by Piper Sandler
Essa Pharma Cut to Perform From Outperform by Oppenheimer
Oppenheimer Downgrades ESSA Pharma(EPIX.US) to Hold Rating
Piper Sandler Downgrades ESSA Pharma(EPIX.US) to Hold Rating, Cuts Target Price to $2
Essa Pharma Downgraded to Neutral From Overweight at Piper Sandler
Express News | ESSA Pharma Inc : Jefferies Cuts Target Price to $1.7 From $16
ESSA Pharma EPIX Phase 2 Termination; Lexicon LXRX Advisory Committee
Top Midday Decliners
Trending Stocks Today | Vast Renewables Shoots up 155.5%
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
Why Charter Communications Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Sector Update: Health Care Stocks Flat to Higher Pre-Bell Friday
Analysis
Price Target
No Data
No Data